Pathstone Holdings, LLC Alkermes Plc. Transaction History
Pathstone Holdings, LLC
- $22.8 Billion
- Q1 2025
A detailed history of Pathstone Holdings, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 99,549 shares of ALKS stock, worth $3.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,549
Previous 84,992
17.13%
Holding current value
$3.11 Million
Previous $2.44 Million
34.49%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$910 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$570 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$369 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$251 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$215 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.14B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...